Biographical Sketch

Romina Gamberale, PhD

 

 

 

Independent Researcher - CONICET
e-mail: rominagamberale@gmail.com


Current Affiliation

Independent Researcher from CONICET, Co-Director of the Laboratory of Onco-Immunology in the Institute of Experimental Medicine (IMEX), CONICET – National Academy of Medicine (ANM) and Faculty Member at the University of Buenos Aires (UBA).

Education and Training

Dr. Gamberale attended University of Buenos Aires where she majored in Cellular Biology in 1998 and received her Ph.D. in Cellular Biology in 2002 at the University of Buenos Aires studying the role of the microenvironment in Chronic Lymphocytic Leukemia (CLL) under the mentorship of Dr. Mirta Giordano. She obtained a fellowship of the French Society of Cancer to attend to Marie Curie Institute in Paris in 2001 to study the role of the tyrosine kinase Syk in dendritic cell maturation, under the supervision of Dr. Sebastian Amigorena. Then, in 2003 she attended Pasteur Institute in Paris under the supervision of Dr. Guillermo Dighiero to study the mutational status of CLL patients.

Professional Experience

Dr. Gamberale has served as Director of IMEX-CONICET (2023–2024) and vicedirector of the IMEX -CONICET (2020-2023) and currently co-directs the Laboratory of Onco-Immunology. She has been a faculty member teaching Immunology at the School of Medicine, University of Buenos Aires since 1996 and, since 2015, co-coordinates the Immunology Course of the Hematology Training Program of the Argentinian Society of Hematology. Her research group investigates how the tumor microenvironment regulates CLL cell activation, proliferation, survival, and therapeutic response.

Leadership and Service

Dr. Gamberale is actively engaged in efforts to advance CLL research regionally and globally. She is a founding member and leadership figure within the Latin American Group on Chronic Lymphocytic Leukemia (LAG-CLL), where she has served in senior scientific and organizational roles aimed at advancing CLL research and collaboration across the region. She participates in the Global Partnerships Subcommittee of the International Workshop on CLL (iwCLL) which aims to improve outcomes of patients with CLL globally.

Research Contributions

Her work has contributed to the understanding of CLL biology and mechanisms of resistance to targeted therapies. She is co-author of clinical consensus documents for the Argentinian Society of Hematology, has supervised numerous undergraduate, doctoral, and postdoctoral researchers, and has published more than 50 peer-reviewed articles in international journals.